<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181118041687N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-09-30</date_registration>
      <primary_sponsor>Larestan University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Nutrition Education in Women with type 2 Diabetes.</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Nutrition Education on Control Blood Sugar, Lipid Profile, liver Enzymes and Quality of life in Middle-aged Women with type 2 Diabetes.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-06-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/35342</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Qualified individuals were randomly assigned to intervention and control groups. (block balanced randomization).
First, I wrote the letters A and B twice on six pieces of paper and put them in a container. Each time I referred, I took a piece of paper at random so that the fourth person could be identified in which group, then I put the paper in the container again I categorized those people into groups A (intervention) and B (control), Blinding description: Only participants are unaware of the allocation of the study groups. The principal investigator is aware of the assignment of groups.
The members of the intervention group were contacted confidentially and were invited to attend training classes.
The control group received training after completing the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Diabetes type 2.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Educational intervention with 4 sessions of nutrition training class in groups of 5-10 people with educational content of sessions including: stages of diabetes progression, symptoms of each stage and its side effects, providing nutritional recommendations to control diabetes and the importance of diet. Food groups and emphasis on increasing the number of meals, reducing the consumption of fats and simple carbohydrates, consuming whole grains and increasing the consumption of fruits and vegetables were held for the intervention group during three months. The average time per session was 70 minutes. The first session at the beginning of the study and in the form of an interactive lecture; The second session was held two weeks after the start of the study by small group techniques, the third session was held four weeks after the start of the study as an interactive lecture and the fourth session was held six weeks after the start of the study by lecture method. It was done by phone and all the recommendations were briefly reminded to the patient again. Intervention 2: Control group:Educational intervention with 4 sessions of nutrition training class in groups of 5-10 people with educational content of sessions including: stages of diabetes progression, symptoms of each stage and its complications, providing nutritional recommendations to control diabetes and the importance of diet. They did not receive any intervention during these three months and were asked not to change their physical activity and diet during this period. But after the intervention, they received all the training provided to the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elham Dezhaloon</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Lar-The old city-square hozeh elmiye-Plaque3</address>
        <city>Lar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>74319-85679</zip>
        <telephone>+98 71 5888 8105</telephone>
        <email>dezhalooneli@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Elham Dezhaloon</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Lar-The old city-square hozeh elmiye-Plaque3</address>
        <city>Lar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>74319-85679</zip>
        <telephone>+98 71 5888 8105</telephone>
        <email>dezhalooneli@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Middle Aged WWomen are 30 to 59 Years Old.
Have a one Year or more History of type 2 Diabetes.
Willing to Participate in the Study.
Use Oral Medications to Control your Blood Sugar.
Do not take Insulin.
Pregnant and lactating.
Do not have any Special iIlnesses.
Have no Thyroid Problems.
There is no Definite Diet.
Do not have Uncontrolled Diabetes.
Have Mental Disabilities.
Sleep, Tranquilizer, Antihistamines and Immune System Inhibitors.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>59 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>One does not want to Continue to Study.
The Person will Absent more than one Meeting.
The Person leaves the Pre-test or Post-test.
Tests are Misleading.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 2 diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Educational intervention with 4 sessions of nutrition training class in groups of 5-10 people with educational content of sessions including: stages of diabetes progression, symptoms of each stage and its side effects, providing nutritional recommendations to control diabetes and the importance of diet. Food groups and emphasis on increasing the number of meals, reducing the consumption of fats and simple carbohydrates, consuming whole grains and increasing the consumption of fruits and vegetables were held for the intervention group during three months. The average time per session was 70 minutes. The first session at the beginning of the study and in the form of an interactive lecture; The second session was held two weeks after the start of the study by small group techniques, the third session was held four weeks after the start of the study as an interactive lecture and the fourth session was held six weeks after the start of the study by lecture method. It was done by phone and all the recommendations were briefly reminded to the patient again.</i_keyword>
      <i_keyword>Control group:Educational intervention with 4 sessions of nutrition training class in groups of 5-10 people with educational content of sessions including: stages of diabetes progression, symptoms of each stage and its complications, providing nutritional recommendations to control diabetes and the importance of diet. They did not receive any intervention during these three months and were asked not to change their physical activity and diet during this period. But after the intervention, they received all the training provided to the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fasting blood glucose above 126mg / dl and high blood glucose levels of 180mg / dl. Timepoint: The beginning of the study (before intervention) and three months after the intervention began. Method of measurement: blood test.</prim_outcome>
      <prim_outcome>Hemogolobin A1C above 6.5%. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Koromatografi.</prim_outcome>
      <prim_outcome>Fasting Ansulin. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Fasting serum insulin concentration using a commercial kit.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Weight. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Weight using seca scales with an accuracy of one hundred grams.</sec_outcome>
      <sec_outcome>Waist. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Scales.</sec_outcome>
      <sec_outcome>Body mass index. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Ratio of weight(in terms of kilogram) to the power of height(in terms of meters).</sec_outcome>
      <sec_outcome>Blood pressure. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Using a standard mercury barometer.</sec_outcome>
      <sec_outcome>High density of lipoprotein cholestrol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Low density of lipoprotein cholestrol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Triglyceride. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Cholesterol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Alanine trans aminase. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Aspartate transaminase. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Homeostasis model assessment beta cell. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Based on fasting glucose and insulin concentrations.</sec_outcome>
      <sec_outcome>Homeostasis model assessment insulin resistance. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Based on fasting glucose and insulin concentrations.</sec_outcome>
      <sec_outcome>Quantitative insulin sensitivity check index. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Based on fasting glucose and insulin concentrations.</sec_outcome>
      <sec_outcome>The level of awareness of people. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Questionnaire of Dr. Faqih et al.</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Twelve quality of life questionnaire.</sec_outcome>
      <sec_outcome>Get food. Timepoint: Three reminders at the beginning of the intervention and three reminders after the end of the educational intervention (Three months after the start of the training intervention). Method of measurement: Using a 24-hour recall form.</sec_outcome>
      <sec_outcome>Physical activity. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Physical activity questionnaire metabolic equivalent Of task (MET).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Shiraz University of Medical Sciences</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz university of medical sciences</source_name>
      <source_name>Shiraz university of medical sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-02-05</approval_date>
        <contact_name>Ethics Committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Shiraz, Razi Blvd, Facing the Power Club, Faculty of Nutrition and Food Sciences Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
